4.7 Review

Glycogen metabolism in cancer

Journal

BIOCHEMICAL PHARMACOLOGY
Volume 92, Issue 1, Pages 3-11

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bcp.2014.09.001

Keywords

Glycogen metabolism; Hypoxia; Pentose shunt; Cancer

Funding

  1. Cancer Research UK [C602/A11359]
  2. Breast Cancer Research Foundation Oxford NHS Biomedical Research Centre [A93022]
  3. CRUK Imaging and Cancer Centre [C5255/A16466]
  4. Federation of European Biochemical Societies (FEBS)
  5. Cancer Research UK [11359] Funding Source: researchfish
  6. National Institute for Health Research [NF-SI-0611-10163] Funding Source: researchfish

Ask authors/readers for more resources

Since its identification more than 150 years ago, there has been an extensive characterisation of glycogen metabolism and its regulatory pathways in the two main glycogen storage organs of the body, i.e. liver and muscle. In recent years, glycogen metabolism has also been demonstrated to be upregulated in many tumour types, suggesting it is an important aspect of cancer cell pathophysiology. Here, we provide an overview of glycogen metabolism and its regulation, with a focus on its role in metabolic reprogramming of cancer cells. The various methods to detect glycogen in tumours in vivo are also reviewed. Finally, we discuss the targeting of glycogen metabolism as a strategy for cancer treatment. (C) 2014 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available